Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Apr 1;156(4):334-342.
doi: 10.1001/jamasurg.2020.6175.

Patient Factors Associated With Parathyroidectomy in Older Adults With Primary Hyperparathyroidism

Affiliations

Patient Factors Associated With Parathyroidectomy in Older Adults With Primary Hyperparathyroidism

Carolyn D Seib et al. JAMA Surg. .

Abstract

Importance: Parathyroidectomy provides definitive management for primary hyperparathyroidism (PHPT), reducing the risk of subsequent fracture, nephrolithiasis, and chronic kidney disease (CKD), but its use among older adults in the US is unknown.

Objective: To identify patient characteristics associated with the use of parathyroidectomy for the management of PHPT in older adults.

Design, setting, and participants: This population-based, retrospective cohort study used 100% Medicare claims from beneficiaries with an initial diagnosis of PHPT from January 1, 2006, to December 31, 2016. Patients were considered to meet consensus guideline criteria for parathyroidectomy based on diagnosis codes indicating osteoporosis, nephrolithiasis, or stage 3 CKD. Multivariable logistic regression was used to identify patient characteristics associated with parathyroidectomy. Data were analyzed from February 11, 2020, to October 8, 2020.

Main outcomes and measures: The primary outcome was parathyroidectomy within 1 year of diagnosis.

Results: Among 210 206 beneficiaries with an incident diagnosis of PHPT (78.8% women; mean [SD] age, 75.3 [6.8] years), 63 136 (30.0%) underwent parathyroidectomy within 1 year of diagnosis. Among the subset of patients who met consensus guideline criteria for operative management (n = 131 723), 38 983 (29.6%) were treated with parathyroidectomy. Patients treated operatively were younger (mean [SD] age, 73.5 [5.7] vs 76.0 [7.1] years) and more likely to be White (90.1% vs 86.0%), to be robust or prefrail (92.1% vs 85.7%), and to have fewer comorbidities (Charlson Comorbidity Index score of 0 or 1, 54.6% vs 44.1%), in addition to being more likely to live in socioeconomically disadvantaged (46.9% vs 40.3%) and rural (18.1% vs 13.6%) areas (all P < .001). On multivariable analysis, increasing age had a strong inverse association with parathyroidectomy among patients aged 76 to 85 years (unadjusted rate, 25.9%; odds ratio [OR], 0.68 [95% CI, 0.67-0.70]) and older than 85 years (unadjusted rate, 11.2%; OR, 0.27 [95% CI, 0.26-0.29]) compared with those aged 66 to 75 years (unadjusted rate, 35.6%), as did patients with moderate to severe frailty (unadjusted rate, 18.9%; OR, 0.60 [95% CI, 0.56-0.64]) compared with robust patients (unadjusted rate, 36.1%) and those with a Charlson Comorbidity Index score of 2 or greater (unadjusted rate, 25.9%; OR, 0.77 [95% CI, 0.75-0.79]) compared with a Charlson Comorbidity Index score of 0 (unadjusted rate, 37.0%). With regard to operative guidelines, a history of nephrolithiasis increased the odds of parathyroidectomy (OR, 1.43 [95% CI, 1.39-1.47]); stage 3 CKD decreased the odds of parathyroidectomy (OR, 0.71 [95% CI, 0.68-0.74]); and osteoporosis showed no association (OR, 1.01 [95% CI, 0.99-1.03]).

Conclusions and relevance: In this cohort study, most older adults with PHPT did not receive definitive treatment with parathyroidectomy. Older age, frailty, and multimorbidity were associated with nonoperative management, and guideline recommendations had minimal effect on treatment decisions. Further research is needed to identify barriers to surgical care and develop tools to target parathyroidectomy to older adults most likely to benefit.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr Seib reported consulting for Virtual Incision Corporation. Dr Suh reported consulting for Medtronic plc, Prescient Surgical, and GLG Pharma Corporation. Dr Finlayson reported being a founding shareholder of Ooney, Inc. No other disclosures were reported.

Figures

Figure 1.
Figure 1.. Cohort Enrollment Criteria
CKD indicates chronic kidney disease; ICD-9/10, International Classification of Diseases, Ninth Revision/International Statistical Classification of Diseases and Related Health Problems, Tenth Revision; PHPT, primary hyperparathyroidism. aThe sum of subcategory totals exceeds the number of total exclusions because some patients met multiple exclusion criteria. bPatients were excluded if age, sex, race/ethnicity, Area Deprivation Index, or urban or rural inhabitance were unknown.
Figure 2.
Figure 2.. Rate of Parathyroidectomy Among Patients Who Did and Did Not Meet Consensus Guideline Criteria for Surgical Management
Data are stratified by age, comorbidity burden, and frailty. Meeting consensus criteria for parathyroidectomy was defined based on a documented diagnosis of osteoporosis, nephrolithiasis, or stage 3 chronic kidney disease.

Comment in

  • Undertreatment of Primary Hyperparathyroidism.
    Almquist M, Nilsson M. Almquist M, et al. JAMA Surg. 2021 Apr 1;156(4):342. doi: 10.1001/jamasurg.2020.6239. JAMA Surg. 2021. PMID: 33404591 No abstract available.
  • Urolithiasis/Endourology.
    Assimos DG. Assimos DG. J Urol. 2021 Dec;206(6):1513-1515. doi: 10.1097/JU.0000000000002207. Epub 2021 Sep 8. J Urol. 2021. PMID: 34494454 No abstract available.

References

    1. Yeh MW, Ituarte PHG, Zhou HC, et al. . Incidence and prevalence of primary hyperparathyroidism in a racially mixed population. J Clin Endocrinol Metab. 2013;98(3):1122-1129. doi:10.1210/jc.2012-4022 - DOI - PMC - PubMed
    1. Yeh MW, Zhou H, Adams AL, et al. . The relationship of parathyroidectomy and bisphosphonates with fracture risk in primary hyperparathyroidism: an observational study. Ann Intern Med. 2016;164(11):715-723. doi:10.7326/M15-1232 - DOI - PubMed
    1. Mollerup CL, Vestergaard P, Frøkjaer VG, Mosekilde L, Christiansen P, Blichert-Toft M. Risk of renal stone events in primary hyperparathyroidism before and after parathyroid surgery: controlled retrospective follow up study. BMJ. 2002;325(7368):807. doi:10.1136/bmj.325.7368.807 - DOI - PMC - PubMed
    1. Assadipour Y, Zhou H, Kuo EJ, Haigh PI, Adams AL, Yeh MW. End-organ effects of primary hyperparathyroidism: a population-based study. Surgery. 2019;165(1):99-104. doi:10.1016/j.surg.2018.04.088 - DOI - PubMed
    1. Coker LH, Rorie K, Cantley L, et al. . Primary hyperparathyroidism, cognition, and health-related quality of life. Ann Surg. 2005;242(5):642-650. doi:10.1097/01.sla.0000186337.83407.ec - DOI - PMC - PubMed

Publication types